Malin Corporation | MLC - Cash And Equivalent

Stock Price
7.45
Daily Change
-0.15 -1.97%
Monthly
-6.88%
Yearly
-12.35%
Q2 Forecast
7.23

Malin Corporation reported EUR62.1M in Cash and Equivalent for its fiscal semester ending in December of 2024.





Cash And Equivalent Change Date
Akebia Therapeutics USD 162.64M 22.2M Mar/2026
Alaunos Therapeutics USD 354K 1.03M Mar/2026
ALKERMES USD 351.55M 37.02M Mar/2026
Avita Medical AUD 10.24M 1.98M Dec/2025
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Eurofins Scientific SE EUR 791.2M 37.9M Dec/2025
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
Lonza CHF 719M 188M Dec/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Moderna USD 1.91B 687M Mar/2026
Organon & Co USD 1.12B 542M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Tectonic Therapeutic USD 236.89M 16.9M Mar/2026
Viatris USD 1.8B 481.8M Mar/2026
Xeris Pharmaceuticals USD 111.75M 708K Mar/2026